We are live on ! Find out more
BTW

Boston Trust Walden Portfolio holdings

AUM $13.1B
1-Year Est. Return 24.63%
This Fund
S&P 500
This Quarter Est. Return
+7.94%
1 Year Est. Return
+24.63%
3 Year Est. Return
+61.41%
5 Year Est. Return
+82.17%
10 Year Est. Return
+348.28%
AUM
$6.82B
AUM Growth
+$400M
Cap. Flow
-$64.1M
Cap. Flow %
-0.94%
Top 10 Hldgs %
17.87%
Holding
394
New
21
Increased
124
Reduced
197
Closed
10

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$14.8M
2
HSIC icon
Henry Schein
HSIC
+$14.3M
3
HON icon
Honeywell
HON
+$14.2M
4
MD icon
Pediatrix Medical
MD
+$13.5M
5
CRL icon
Charles River Laboratories
CRL
+$13.3M

Top Sells

Rank Stock Value
1
BCR
CR Bard Inc.
BCR
+$62.1M
2
CVS icon
CVS Health
CVS
+$18M
3
ACH
Accendra Health
ACH
+$14.8M
4
UI icon
Ubiquiti
UI
+$13.1M
5
EGBN icon
Eagle Bancorp
EGBN
+$11.4M

Sector Composition

Rank Sector Weight
1 Financials 19.36%
2 Healthcare 15.63%
3 Technology 15.4%
4 Industrials 13.63%
5 Consumer Discretionary 8.69%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
CBT icon
326
Cabot Corp
CBT
$4.65B
$617K 0.01%
10,014
– –
CELG
327
DELISTED
Celgene Corp
CELG
$615K 0.01%
5,890
-1,000
-15% -$113K
IJH icon
328
iShares Core S&P Mid-Cap ETF
IJH
$123B
$608K 0.01%
16,010
– –
BEN icon
329
Franklin Resources
BEN
$16.9B
$578K 0.01%
13,330
– –
SO icon
330
Southern Company
SO
$110B
$563K 0.01%
11,711
– –
RDS.A
331
DELISTED
Royal Dutch Shell PLC ADS Class A
RDS.A
$533K 0.01%
7,988
-181
-2% -$11.4K
LHX icon
332
L3Harris
LHX
$55.9B
$524K 0.01%
3,700
-287
-7% -$40.1K
IWB icon
333
iShares Russell 1000 ETF
IWB
$47.7B
$510K 0.01%
3,432
– –
TGT icon
334
Target
TGT
$62.1B
$506K 0.01%
7,750
-950
-11% -$57.4K
TMO icon
335
Thermo Fisher Scientific
TMO
$211B
$506K 0.01%
2,663
– –
CERN
336
DELISTED
Cerner Corp
CERN
$484K 0.01%
7,175
– –
EFA icon
337
iShares MSCI EAFE ETF
EFA
$76.4B
$473K 0.01%
6,723
+350
+5% +$24.3K
TM icon
338
Toyota
TM
$210B
$464K 0.01%
+3,648
New +$455K
VSM
339
DELISTED
Versum Materials, Inc.
VSM
$464K 0.01%
12,260
-11,174
-48% -$436K
NOC icon
340
Northrop Grumman
NOC
$77B
$462K 0.01%
1,506
-84
-5% -$25.2K
AVGO icon
341
Broadcom
AVGO
$1.82T
$455K 0.01%
17,710
-300
-2% -$7.8K
REGN icon
342
Regeneron Pharmaceuticals
REGN
$68.8B
$451K 0.01%
1,200
+150
+14% +$60.8K
NVO
343
Novo Nordisk
NVO
$216B
$441K 0.01%
+16,450
New +$418K
DUK icon
344
Duke Energy
DUK
$102B
$440K 0.01%
5,234
-467
-8% -$40.8K
SCHW
345
Charles Schwab
SCHW
$177B
$433K 0.01%
8,430
– –
INGR icon
346
Ingredion
INGR
$6.38B
$419K 0.01%
3,000
– –
IWR icon
347
iShares Russell Mid-Cap ETF
IWR
$56.8B
$404K 0.01%
7,760
+500
+7% +$25.4K
QUAL icon
348
iShares MSCI USA Quality Factor ETF
QUAL
$45.9B
$392K 0.01%
4,727
– –
VT icon
349
Vanguard Total World Stock ETF
VT
$76.3B
$360K 0.01%
4,850
– –
BCE icon
350
BCE
BCE
$19.9B
$356K 0.01%
+7,415
New +$353K
12 13
14
15 16

Similar funds

TWIM
TIAA Wealth Investment Management New York $13.1B AUM
PFPG
Pinnacle Financial Partners (Georgia) Atlanta, Georgia $13.1B AUM
RCMU
Rokos Capital Management (UK) London, United Kingdom $13.2B AUM 85.71% 1-Year Est. Return
EPFB
Employees Provident Fund Board Shah Alam, Malaysia $13.2B AUM 29.65% 1-Year Est. Return
NMIFOAC
National Mutual Insurance Federation of Agricultural Cooperatives Tokyo, Japan, Japan $13B AUM 17.65% 1-Year Est. Return
AAMU
APG Asset Management US New York $13B AUM 5.3% 1-Year Est. Return
MGIA
Moneta Group Investment Advisors St Louis, Missouri $13.3B AUM 18.65% 1-Year Est. Return
TG
TCW Group Los Angeles, California $13.3B AUM 34.44% 1-Year Est. Return

Boston Trust Walden's Q4 2017 Portfolio in Review

As of Q4 2017, Boston Trust Walden held 394 positions worth $6.82B, up 6.2% from $6.42B the previous quarter. Its ten largest holdings account for 18% of the portfolio.

Boston Trust Walden's Q4 2017 filing shows 21 new, 124 increased, 197 reduced and 10 closed positions. Its largest new stake was Charles River Laboratories: 122,536 shares worth $13.4M. The largest sale was CR Bard Inc., an estimated $62.1M.

By sector, the portfolio is most concentrated in Financials at 19% of assets, down from 19% a quarter earlier, followed by Healthcare and Technology.

  • Boston Trust Walden's largest Q4 2017 buy was Charles River Laboratories: 122,536 shares worth $13.4M.
  • Boston Trust Walden added most to Becton Dickinson in Q4 2017, an estimated $14.8M increase.
  • Boston Trust Walden's biggest Q4 2017 reduction was CVS Health, cutting an estimated $18M.
  • Boston Trust Walden fully exited CR Bard Inc. in Q4 2017, selling an estimated $62.1M.
  • Boston Trust Walden's ten largest holdings make up 18% of its $6.82B portfolio in Q4 2017.
  • Boston Trust Walden opened 21 new positions and closed 10 in Q4 2017.
  • Boston Trust Walden's portfolio value rose 6.2% quarter-over-quarter to $6.82B.

Based on Boston Trust Walden's 13F filing for Q4 2017, filed 29 Jan 2018.